To test the impact of aging-related immune changes on cardiovascular health, percentages and cell numbers of CD8+ TNAIVE, CD8+ TEMRA cells and intermediate monocytes were further compared between patients with and without coronary artery disease (CAD) and between patients with and without cardiovascular disease (CVD). The gene discussed is CD8A; the disease is coronary artery disorder.